Skip to main content
Sinopharm Tech Holdings Limited logo

Sinopharm Tech Holdings Limited — Investor Relations & Filings

Ticker · 8156 ISIN · KYG2159V1418 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,470 across all filing types
Latest filing 2025-10-23 Board/Management Inform…
Country HK Hong Kong
Listing HKEX 8156

About Sinopharm Tech Holdings Limited

http://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Limited is an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business. The company focuses on the trading and distribution of medical and related products, including Chinese patent medicines and health products, targeting the market in the PRC. It develops its supply chain operations using "Internet Plus" services, leveraging technology to provide value-added services to industry operators and product suppliers. The Group is also integrating AI analytics to enhance its operations within the healthcare sector.

Recent filings

Filing Released Lang Actions
CHANGE OF COMPANY SECRETARY
Board/Management Information Classification · 95% confidence The document is a public announcement on The Stock Exchange of Hong Kong Limited regarding the resignation and appointment of the company secretary (a senior management change). It contains no financial results, no meeting voting details, and no report attachments. This clearly falls under Board/Management Information (senior management changes).
2025-10-23 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2025
Regulatory Filings Classification · 85% confidence The document is the FF301 “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts” filed under Chapter 19B of the HKEX Listing Rules, detailing authorised share capital, issued shares, share options, convertibles, and confirmations. It is a mandatory periodic regulatory return rather than an annual or interim report, earnings release, dividend notice, or any management or proxy document. It does not announce the publication of another report but is itself a regulatory filing. Therefore it falls under the general "Regulatory Filings" category.
2025-10-08 English
ANNUAL REPORT 2025
Annual Report Classification · 100% confidence The document is explicitly titled '2025 ANNUAL REPORT' and contains standard sections for an annual report, including 'Corporate Information', 'Management Discussion and Analysis', 'Contents', and references to 'Independent Auditor's Report' and 'Consolidated Financial Statements'. It covers the fiscal year ended 30 June 2025 and provides a comprehensive overview of the company's business, strategy, and financial outlook, fitting the definition of a 10-K (Annual Report). FY 2025
2025-09-26 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 30 JUNE 2025
Annual Report Classification · 100% confidence The document is titled 'ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 30 JUNE 2025' and explicitly contains the full text of the 'Annual Report 2025' for Sinopharm Tech Holdings Limited. It includes comprehensive financial statements, management discussion and analysis, and auditor reports. Since it is the complete annual report rather than just an announcement of one, it is classified as a 10-K (Annual Report). FY 2025
2025-09-26 English
PROFIT ALERT - SUBSTANTIAL REDUCTION IN LOSS
Earnings Release Classification · 92% confidence The document is a “Profit Alert” announcing preliminary, unaudited financial results for the year ended 30 June 2025 in line with listing rules, providing only key highlights (significant reduction in loss) and a projected date for the formal results. This fits the definition of an Earnings Release (initial announcement of periodical financial results, key highlights only). It is not the full annual report, nor a mere notice of publication, but a preliminary earnings announcement under GEM Listing Rule 17.10. FY 2025
2025-09-22 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 85% confidence The document is a short Hong Kong Stock Exchange announcement scheduling a Board meeting to consider and approve annual results and other items. It is not the full annual report or financial results, nor does it announce an actual report publication or contain substantive financial statements. It does not report a change in management or directors, nor is it an AGM material, dividend notice, or earnings release. This is a regulatory announcement (fallback) of corporate actions under exchange rules. Therefore, it falls under Regulatory Filings (RNS).
2025-09-16 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.